Aptimmune Biologics Inc

Aptimmune Biologics Inc., based in Champaign, IL, specializes in developing advanced vaccines to combat significant swine pathogens such as the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and Swine Influenza A virus (IAV-S). The company utilizes its proprietary BarricadeR platform technology and is also focused on creating vaccines for the African Swine Fever virus (ASFV), addressing critical needs in the agriculture sector.

In recent developments, Aptimmune has successfully completed Series B funding and forged strategic partnerships, enhancing its role in the ag tech landscape. Recognized for its innovative approaches, the company was honored with Iowa Biotech's Top Company Award and has been selected for the Yield Lab's Ag Tech Accelerator Program.

Generated from the website